Recently, the General Election and Academic Exchange Conference of the Special Committee for Human Use Experience and Medical Institution Preparation Transformation of Guangdong Chinese Medicine Association was successfully held at the First Affiliated Hospital of Guangzhou University of Chinese Medicine.

Li Yongxue, President of Guangdong Chinese Medicine Association, attended and addressed the meeting. Qiu Zhenwen, Chairperson of the 1st Special Committee, delivered a work report and was re-elected as Chairperson of the 2nd Special Committee. Yang Zhongqi, Vice President of the First Affiliated Hospital of Guangzhou University of Chinese Medicine and the first Chairperson of the Special Committee, delivered a speech and presented an academic report titled *Clinical Trials of New Traditional Chinese Medicine Products Based on Human Use Experience*.

▲ Li Yongxue delivering a speech

▲ Qiu Zhenwen presenting the work plan

▲ Yang Zhongqi giving remarks

Following a rigorous election process, Ms. Zhou Jie, Founder and General Manager of Guangzhou Evidence-based Pharmaceutical Technology Co., Ltd., was formally appointed Vice Chairperson of the 2nd Special Committee for her profound expertise in systematic summarization of human use experience and research on medical institution preparation transformation. Meanwhile, Ms. Wu Yanmei, Deputy General Manager of the company, was appointed Secretary of the 2nd Special Committee to assist with daily academic exchanges and project promotion.

Founded in 2016, Guangzhou Evidence-based Pharmaceutical Technology Co., Ltd. is a platform dedicated to high-quality full-industry-chain services for TCM research and development. It focuses on core businesses including clinical trials of new TCM drugs, summary of human use experience and transformation of medical institution preparations. The company has obtained ISO9001 quality management system certification and the certification of technology-based small and medium-sized enterprises. It has also been recognized as a High-tech Enterprise and a Specialized, Refined, Differential and Innovative Small and Medium-sized Enterprise in Guangdong Province, earning a solid professional reputation in the industry.

Ms. Zhou Jie’s new role will further strengthen the company’s collaboration with the Special Committee, top medical institutions and research institutes. Going forward, adhering to the philosophy of “Prove the wisdom of traditional Chinese medicine with modern evidence-based technology”, Guangzhou Evidence-based Pharmaceutical will actively participate in the work of the Special Committee. It will contribute its strength to advancing the standardized, industrialized and innovative development of medical institution preparations in Guangdong and building the Greater Bay Area highland for traditional Chinese medicine.